Business
American Vanguard makes and markets agricultural, commercial, and consumer crop protection and specialty chemical products through AMVAC and related subsidiaries.
American Vanguard revenue fell, but losses narrowed and margins improved, while cash flow, debt, equity, and dividends weakened.
The read at a glance✓ Audited against SEC data
- Business mix — Agricultural and specialty chemicalsNote
- Revenue — Revenue fell 5.9%Watch
- Losses — Net loss narrowed to $49.9MOK
- Cash — Cash from ops turned negativeWatch
- Balance sheet — Debt rose; equity fellWatch
- Insiders — 0 buys / 1 sellWatch
- Accounting — Altman-Z grey; EQ greyWatch
Where the revenue comes from
Fiscal 2025, as AMERICAN VANGUARD CORP reports it. History and quarterly detail are in the app.
- US Crop$221.4M
- US Non Crop$90.3M
Leadership changes
From AMERICAN VANGUARD CORP's own filings, the day they're filed.
- Carmen Tiu de Mino · departureeff. 2026-04-10
- Carmen Tiu · appointmenteff. 2024-12-11
- Debra Edwards · directors · departureeff. 2024-12-10
Latest filings
- 8-K · Company announcement2026-08-11
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-06-08
- 10-Q · Quarterly report2026-05-06
- DEF 14A · Annual proxy (pay & governance)2026-04-23
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about AMERICAN VANGUARD CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.